Save information for later
Sign Up

Learn About Recurrent Respiratory Papillomatosis

What is the definition of Recurrent Respiratory Papillomatosis?
Recurrent respiratory papillomatosis (RRP) is a rare viral disease where tumors (papillomas) grow in the air passages leading from the nose and mouth into the lungs (respiratory tract). There are two types, a juvenile-onset form and an adult-onset form. The tumors can cause a hoarse voice, chronic cough, and difficulty breathing. They may vary in size and grow very quickly, and may grow back even when removed. These tumors rarely become cancerous, but can cause long-term airway and voice complications. RRP is caused by two types of human papillomavirus (HPV), called HPV 6 and HPV 11. It is transmitted from an infected mother to her baby through the placenta or through the birth canal. HPV can also be transmitted from one adult to another through oral sex. The HPV vaccine can help prevent infection.
What are the alternative names for Recurrent Respiratory Papillomatosis?
  • Recurrent respiratory papillomatosis
  • AORRP (type)
  • Adult-onset recurrent respiratory papillomatosis (type)
  • JORRP (type)
  • Juvenile laryngeal papilloma
  • Juvenile-onset recurrent respiratory papillomatosis (type)
  • Laryngeal papilloma, recurrent
  • RRP
  • Respiratory papillomatosis, recurrent
Who are the top Recurrent Respiratory Papillomatosis Local Doctors?
Internal Server Error
Try again later - Or try changing your parameters
What are the latest Recurrent Respiratory Papillomatosis Clinical Trials?
A Phase II Study of Bevacizumab in Adults With Recurrent Respiratory Papillomatosis (RRP)

Background: Recurrent respiratory papillomatosis (RRP) is a rare disease that causes wart-like growths in the airways. These growths come back when removed; some people may need 2 or more surgeries per year to keep their airways clear. Better treatments are needed.

Match to trials
Find the right clinical trials for you in under a minute
Get started
A Phase II Study of Lenvatinib in Combination With Pembrolizumab in HPV-associated Recurrent Respiratory Papillomatosis Patients

Summary: This research study is studying Lenvatinib in combination with Pembrolizumab in people with human papillomavirus (HPV)-associated recurrent respiratory papillomatosis (RRP). The names of the study drugs involved in this study are: * Pembrolizumab * Lenvatinib

Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center